Assembly Biosciences, Inc. (ASMB) Free cash flow 2016–2025
Assembly Biosciences, Inc. (ASMB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$41.2MFY2025 · since FY2016: -$35.0M → -$41.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$41.2M | +19.5% |
| FY2024 | -$51.1M | -327.4% |
| FY2023 | $22.5M | +126.6% |
| FY2022 | -$84.6M | +12.4% |
| FY2021 | -$96.5M | -52.1% |
| FY2020 | -$63.4M | +25.9% |
| FY2019 | -$85.6M | -31.1% |
| FY2018 | -$65.3M | -6662.6% |
| FY2017 | $995,000 | +102.8% |
| FY2016 | -$35.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice